Clover Health Investments Corp. [NASDAQ: CLOV] traded at a low on 03/16/21, posting a -2.99 loss after which it closed the day’ session at $8.61. The company report on March 17, 2021 that SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Clover Health Investments, Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm.
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Clover Health Investments, Corp. f
Investors who purchased or otherwise acquired publicly traded Clover securities between October 6, 2020 and February 4, 2021, inclusive (the “Class Period”); and/or purchased or otherwise acquired Clover securities pursuant or traceable to the registration statement and prospectus issued in connection with the December 2020 Merger of Clover and Social Capital III, are encouraged to contact the firm before April 6, 2021.
The results of the trading session contributed to over 8328720 shares changing hands. Over the past one week, the price volatility of Clover Health Investments Corp. stands at 7.57% while the volatility over the past one month is 10.07%.
The market cap for CLOV stock reached $3.39 billion, with 103.50 million shares outstanding and 86.67 million shares in the current float. Compared to the average trading volume of 17.70M shares, CLOV reached a trading volume of 8328720 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Clover Health Investments Corp. [CLOV]?
Credit Suisse have made an estimate for Clover Health Investments Corp. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on March 09, 2021. While these analysts kept the previous recommendation, Citigroup raised their target price to Buy. The new note on the price target was released on February 02, 2021, representing the official price target for Clover Health Investments Corp. stock. Previously, the target price had yet another raise to $15, while JP Morgan analysts kept a Neutral rating on CLOV stock.
The Average True Range (ATR) for Clover Health Investments Corp. is set at 0.94, with the Price to Sales ratio for CLOV stock in the period of the last 12 months amounting to 4.91. The Price to Book ratio for the last quarter was 1.12, with the Price to Cash per share for the same quarter was set at 0.00.
How has CLOV stock performed recently?
Clover Health Investments Corp. [CLOV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.13. With this latest performance, CLOV shares dropped by -28.73% in over the last four-week period, additionally sinking by -26.72% over the last 6 months.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLOV stock in for the last two-week period is set at 40.15, with the RSI for the last a single of trading hit 42.55, and the three-weeks RSI is set at 40.15 for Clover Health Investments Corp. [CLOV]. The present Moving Average for the last 50 days of trading for this stock 12.01, while it was recorded at 8.64 for the last single week of trading.
Clover Health Investments Corp. [CLOV]: Deeper insight into the fundamentals
Reflecting on the efficiency of the workforce at the company, Clover Health Investments Corp. [CLOV] managed to generate an average of -$4,408 per employee.Clover Health Investments Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.30 and a Current Ratio set at 0.30.
Insider trade positions for Clover Health Investments Corp. [CLOV]
There are presently around $156 million, or 13.60% of CLOV stock, in the hands of institutional investors. The top three institutional holders of CLOV stocks are: SUSQUEHANNA INTERNATIONAL GROUP, LLP with ownership of 2,147,623, which is approximately New of the company’s market cap and around 0.30% of the total institutional ownership; GROUP ONE TRADING, L.P., holding 1,915,441 shares of the stock with an approximate value of $16.49 million in CLOV stocks shares; and ALYESKA INVESTMENT GROUP, L.P., currently with $15.37 million in CLOV stock with ownership of nearly 156.643% of the company’s market capitalization.
Positions in Clover Health Investments Corp. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 79 institutional holders increased their position in Clover Health Investments Corp. [NASDAQ:CLOV] by around 14,187,911 shares. Additionally, 79 investors decreased positions by around 46,838,430 shares, while 1 investors held positions by with 42,915,098 shares. The mentioned changes placed institutional holdings at 18,111,243 shares, according to the latest SEC report filing. CLOV stock had 67 new institutional investments in for a total of 12,014,953 shares, while 66 institutional investors sold positions of 33,969,301 shares during the same period.